Despite the existence of conventional medications to manage multiple sclerosis (MS) symptoms, a majority of patients also rely on alternative therapies, including vitamins, exercise and marijuana, a new survey suggests.
For the study, researchers at Oregon Health and Science University in Portland asked MS patients if they used "complementary and alternative therapies" -- medicines a...
Air pollution might increase the risk for multiple sclerosis (MS), Italian researchers report.
They found that in places with low levels of tiny particles of air pollution called particulate matter, the risk for MS was lower than in areas where those levels were high. In urban areas, the risk was 29% higher than in rural areas.
A new blood test might help doctors predict whether someone's multiple sclerosis may soon get worse.
The test looks for a substance called neurofilament light chain. It's a nerve protein that can be detected when nerve cells die. People with higher levels of it were more likely to have worsening MS effects within the next year.
Multiple sclerosis can cause weakness, pain, fatigue and vision problems. The disease also appears to increase the odds of heart disease and stroke, new research suggests.
Multiple sclerosis (MS) is a central nervous system disorder that can affect movement. The British study found that people with MS were nearly one-third more likely to have "macrovascular disease." Those are condit...
Brain inflammation may be more of a factor in dementia than previously believed, a new British study suggests.
"We predicted the link between inflammation in the brain and the buildup of damaging proteins, but even we were surprised by how tightly these two problems mapped on to each other," said co-author Thomas Cope of the Department of Clinical Neurosciences at the University of Ca...
The cost of essential medications for multiple sclerosis have nearly tripled this decade, despite the release of the first generic MS drug, a new study shows.
The 2015 release of glatiramer acetate -- the generic version of Copaxone -- did nothing to halt skyrocketing prices for MS medications, said lead researcher Daniel Hartung. He's an associate professor of pharmacy with Oregon St...
If you have a neurological disorder, a video chat with your doctor might be as good as an office visit for checking on your condition.
That's the conclusion of researchers who analyzed 101 studies on telemedicine use for concussion, traumatic brain injury, dementia, epilepsy, headache, multiple sclerosis, movement disorders, neuromuscular conditions and general neurology.
A variant of a common herpes virus may play a role in the development of multiple sclerosis (MS), Swedish researchers say.
They analyzed the blood of about 8,700 MS patients and a control group of more than 7,200 people without MS. They were looking for antibodies against proteins of two variants (A and B) of human herpesvirus 6 (HHV-6), which has been linked with MS.
Medicare patients with multiple sclerosis (MS) saw their medication costs soar by more than sevenfold over a decade, a new study finds.
It's no secret that the costs of MS drugs have skyrocketed in recent years. When the first so-called disease-modifying drugs were approved starting in the 1990s, they cost roughly $8,000 to $11,000 per year, according to the National Multiple Sclerosi...
Surgery is safe for people with multiple sclerosis (MS), a new study finds.
"The idea that patients with MS might be at an increased risk of relapse following surgery isn't necessarily the case, so we need to be careful delaying important surgeries," said study first author Dr. Lindsey De Lott. She is an assistant professor of neurology at the University of Michigan, in Ann Arbor.
Obesity can worsen multiple sclerosis symptoms, researchers say.
Their study involved 140 patients with the relapsing-remitting form of MS, which means patients have periods of attacks (relapses), followed by periods of remission with no or few symptoms. The researchers found that obesity at the time of diagnosis was associated with more severe disability.
Multiple sclerosis, epilepsy and Parkinson's can be physically taxing conditions, but new research shows they exact a huge financial toll as well.
Over a 12-year period, out-of-pocket costs for Americans with these illnesses jumped, with the biggest increase seen among people with multiple sclerosis (MS). Those patients paid 20 times more for their drugs in 2016 than they did in 2004...
Almost one in five multiple sclerosis patients may be misdiagnosed with the autoimmune disease, according to a new study.
Of 241 previously diagnosed multiple sclerosis (MS) patients referred to two major Los Angeles medical centers for treatment, nearly 18% did not actually have the autoimmune disease, the researchers found.
The U.S. Food and Drug Administration has approved another new multiple sclerosis drug -- the second in one week.
Mavenclad (cladribine) pills can be used to treat relapsing forms of MS in adults, including relapsing-remitting disease and active secondary progressive disease. The drug is not recommended for MS patients with a course of the disease known as clinically isolated syndrome...
A new pill for relapsing forms of multiple sclerosis (MS) has won approval from the U.S. Food and Drug Administration.
Generally, relapsing MS involves periods of worsening symptoms followed by recovery periods. Over time, some disability follows independent of relapses, and this is called secondary progressive multiple sclerosis, or SPMS.
Fatigue can plague many people with multiple sclerosis (MS). But a small new study suggests a soothing cup of hot cocoa may bring some relief.
Like dark chocolate, cocoa is rich in flavonoids, which are abundant in fruit and vegetables and have been linked with anti-inflammatory properties, explained researcher Shelly Coe, of the Center for Nutrition and Health at Oxford Brookes Univ...
Medicare rule changes could trigger a spike in out-of-pocket drug costs for patients with multiple sclerosis (MS).
Due to rules that restrict access and require patients to cover more of the cost, those without low-income subsidies can expect to spend almost $6,900 a year out of pocket for MS medicines, researchers reported.
"It's a dysfunctional market that lacks the typica...
A stem cell transplant may help some people with multiple sclerosis (MS) when standard drugs fail, a new clinical trial finds.
The study focused on 110 patients with aggressive cases of MS: Their symptoms had flared up at least twice in the past year despite taking standard medication, and they'd already tried an average of three of those drugs.
Researchers say they've identified a potential link between food allergies and flare-ups of multiple sclerosis.
"Our findings suggest that MS patients with allergies have more active disease than those without, and that this effect is driven by food allergies," said study author Dr. Tanuja Chitnis, an MS specialist, and colleagues.
A new warning has been added to the multiple sclerosis drug Lemtrada (alemtuzumab) after rare reports of patients suffering strokes and tears in the lining of the arteries in the head and neck, the U.S. Food and Drug Administration said.
Most patients with these problems -- which can lead to permanent disability and death -- developed symptoms within a day of receiving an initial infu...
Medical products derived from marijuana might have a mild benefit in treating symptoms of multiple sclerosis, based on reports from patients.
Drugs containing the major chemical compounds in cannabis are associated with a limited and mild reduction in muscle contractions, bladder dysfunction and pain, based on patient self-assessments from clinical trials included in a major new evide...
Living with a potentially disabling condition like multiple sclerosis (MS) can be difficult, but new research suggests patients get better at dealing with it over time.
"There's an aging paradox in healthy adults. We expect people who are older to be more depressed and anxious because of aging processes [such as physical aches and pain and losing friends and family], but instead, peo...
A drug that has long been used in Japan for asthma may slow down brain shrinkage in people with progressive multiple sclerosis, a preliminary trial has found.
The study, published Aug. 30 in the New England Journal of Medicine, tested an oral drug called ibudilast. It is not approved in the United States, but has been used for years in Japan as a treatment for asthma and for ve...
A new subtype of multiple sclerosis (MS) has been identified by researchers, and the discovery changes understanding of the disease.
MS has long been considered a disease of the brain's white matter, where immune cells destroy the fatty protective covering (myelin) on nerve cells. The destruction of myelin (demyelination) is linked to nerve cell death that leads to progressive disabi...